ArticleClinical epigenetics2022

CRNDE acts as an epigenetic modulator of the p300/YY1 complex to promote HCC progression and therapeutic resistance.

Yu-Chin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.